The largest database of trusted experimental protocols

Automated elispot counter

Manufactured by Cellular Technology
Sourced in United States

The Automated ELISPOT Counter is a laboratory instrument designed to detect and quantify the number of cytokine-producing cells in a given sample. It employs the ELISPOT (Enzyme-Linked Immunospot) technique, which is a sensitive method for the detection of individual cells secreting specific proteins. The core function of the Automated ELISPOT Counter is to accurately and efficiently count the number of spots, representing the cytokine-secreting cells, in an ELISPOT assay.

Automatically generated - may contain errors

5 protocols using automated elispot counter

1

Enumeration of Antigen-Specific Antibody-Secreting Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A direct enzyme-linked immunospot (ELISpot) assay was used to enumerate the numbers of total IgG, IgA and IgM ASCs and the H3N2-specific IgG, IgA, and IgM ASCs present in fresh PBMCs, performed as described previously [10 (link)]. 96-well ELISpot filter plates (Millipore, Burlington, MA, USA), #MAHA N4510) were coated overnight with purified A/Minnesota/11/2010 H3N2v virus or rHAs of contemporary H3N2 strains in PBS, or goat anti-human Ig (Jackson ImmunoResearch Laboratory, Inc., West Grove, PA, USA). Plates were washed and blocked 2 h at 37 °C prior to use with RPMI 1640 containing 10% fetal calf serum, 100 units/mL of penicillin G, and 100 μg/mL of streptomycin (Gibco), referred to as complete medium. Freshly isolated PBMC were suspended in complete medium distributed into ELISpot plates and incubated overnight at 37 °C in a CO2 incubator. ASCs were detected with biotinylated anti-human IgG, IgM, or IgA antibody (Jackson ImmunoResearch Laboratory Inc., West Grove, PA, USA) followed by incubation with Avidin-D-HRP conjugate (Vector Laboratories, Burlingame, CA, USA), and then developed using AEC substrate (3 amino-9 ethyl-carbazole; Sigma-Aldrich, St. Louis, MO, USA). Developed plates were scanned and analyzed using an automated ELISpot counter (Cellular Technologies, Ltd., Shaker Heights, OH, USA).
+ Open protocol
+ Expand
2

ELISPOT Assay for Antibody-Secreting Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Filter plates (96-well; Millipore) were incubated overnight at 4°C with anti-human IgG, IgA, and IgM (KPL), 2μg/ml recombinant HAs, 2μg/ml recombinant NAs or 32 HAU/well of whole virus. The plates were washed and blocked by incubation with RPMI containing 10% FBS at 37°C for 2 hours. Freshly isolated human PBMCs or mouse spleen cells were washed three times and were re-suspended in medium (RPMI medium supplemented with 4 mM L-glutamine, 10 mM HEPES, 100 U/ml Pen/Step, 10% FBS). The cells (0.5–1-10E6) underwent 2-fold serial dilutions before being transferred to the ELISPOT plates, which were incubated overnight at 37°C. The plates were washed extensively with PBS and PBS–0.05% Tween before antibody from the antibody-secreting cells (ASC) were detected with either 1:1000 biotinylated anti-human IgG (Mabtech) and biotinylated anti-human IgA (Southern Biotech) or a 1:10000 biotinylated anti-mouse IgG. After a 2 hour incubation at room temperature (RT), a 1:500 dilution of streptavidin-alkaline phosphatase (Southern Biotech) was added to each well. The incubation was repeated before ASC spots were revealed with nitroblue tetrazolium/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP; Thermo Scientific). The developed plates were scanned using an automated ELISPOT counter (Cellular Technologies, Ltd.).
+ Open protocol
+ Expand
3

ELISPOT Assay for Human IgG Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ninety-six well filter plates (Millipore–MSHAN4B50) were coated with either VZV cell lysate (Meridian Life Sciences) at 5 μg/well or Affinipure donkey anti-human IgG (H+L; Jackson Immunoresearch) at 100 ng/well in PBS overnight at 4°C. The plates were washed with PBS four times and complete FBS media added for 2 hr at 37°C. Freshly prepared PBMCs were resuspended in complete FBS media at 1×107/ml and added to each well, followed by threefold dilution and then incubated overnight at 37°C. The next day, the plates were washed four times with PBS, four times with PBS-T and incubated for 1.5 hr at room temperature with Biotin-SP-Affinipure F(ab′)2 donkey anti-human IgG (Jackson Immunoresearch) at 100 ng/well in PBS + 10% FCS + 0.05% Tween 20 (PBS-T-FBS). Plates were washed four times with PBS-T and incubated for 1.5 hr with HRP-avidin D (Vector laboratories) at 1:1000 in PBS-T-FBS. Plates were washed four times with PBS-T, four times with PBS and then developed using AEC substrate (3 amino-9 ethyl-carbazole; Sigma Aldrich). Developed plates were dried, scanned and analyzed using an automated ELISPOT counter (Cellular Technologies, Ltd).
+ Open protocol
+ Expand
4

Quantifying Influenza-Specific Memory B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
H3N2 A/Minnesota/11/2010 vaccine antigen was provided by Sanofi Pasteur. Recombinant HA (rHA) from H3N2 A/Perth/16/2009 (NR-19442) was provided by Biodefense and Emerging Infections Research Repository (available at: http://www.beiresources.org); rHA from H3N2 A/Victoria/361/2011 (IRR number, FR-1059) was provided by the IRR. At Emory University School of Medicine, cryopreserved peripheral blood mononuclear cells (PBMCs) collected on day 0 from a subset of participants were thawed in a 37°C water bath and washed. Cells were counted and checked for viability by Trypan blue dye exclusion. MBC assays were performed as previously described [16 (link), 17 (link)]. In brief, PBMCs were plated in 24-well dishes at 5 × 105 cells/well in R-10 medium supplemented with an optimized mix of polyclonal mitogens: pokeweed mitogen extract (made in-house), phosphorothiolated CpG ODN-2006 (Integrated DNA Technologies), and Staphylococcus aureus Cowan (Sigma). Eight wells were cultured per individual for 6 days. Stimulated cells were harvested, washed, and assayed using the ELISpot assay. Developed plates were scanned and analyzed using an automated ELISpot counter (Cellular Technologies). Data are presented as the percentage of influenza virus–specific immunoglobulin G (IgG)–secreting cells among total IgG-secreting cells.
+ Open protocol
+ Expand
5

Enumerating Influenza-Specific Plasmablasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
ELISPOT was performed to enumerate influenza-specific plasmablasts present in PBMC samples. We coated 96-well ELISPOT assay mixed cellulose ester filter plates (Millipore) overnight with either the 2016/2017 Fluarix quadrivalent influenza (GlaxoSmithKline) at 1:20 in PBS or polyvalent goat anti-human Ig (Jackson ImmunoResearch, West Grove, PA, USA) at 10 μg/mL in PBS. The plates were washed and blocked by incubation with R10 media (RPMI-1640 supplemented with 10% FBS, penicillin, streptomycin, and l-glutamine) at 37 °C for 2 h. Freshly isolated PBMCs were added to the plates in a dilution series starting at 5 × 105 cells and incubated overnight at 37 °C in R10 media. The plates were washed with PBS, followed by PBS/0.05% Tween, and then incubated with biotinylated anti-human IgG, IgA, or IgM antibody (Invitrogen) at room temperature for 90 min. After washing, the plates were incubated with avidin D-horseradish peroxidase conjugate (Vector Laboratories) and developed using 3-amino-9-ethylcarbazole substrate (Sigma-Aldrich). Plates were scanned and analyzed using an automated ELISPOT counter (Cellular Technology Limited (CTL)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!